JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004184200 on June 22, 2000

J. Biol. Chem., Vol. 275, Issue 36, 28053-28062, September 8, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/36/28053    most recent
M004184200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, M. K.
Right arrow Articles by Uhler, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, M. K.
Right arrow Articles by Uhler, M. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Amino-terminal Cyclic Nucleotide Binding Site of the Type II cGMP-dependent Protein Kinase Is Essential for Full Cyclic Nucleotide-dependent Activation*

Merritt K. TaylorDagger and Michael D. Uhler§||

From the § Department of Biological Chemistry , the Dagger  Neuroscience Graduate Program, and the  Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48104

For the type I cGMP-dependent protein kinases (cGKIalpha and cGKIbeta ), a high affinity interaction exists between the C2 amino group of cGMP and the hydroxyl side chain of a threonine conserved in most cGMP binding sites. To examine the effect of this interaction on ligand binding and kinase activation in the type II isozyme of cGMP-dependent protein kinase (cGKII), alanine was substituted for the conserved threonine or serine. cGKII was found to require the C2 amino group of cGMP and its cognate serine or threonine hydroxyl for efficient cGMP activation. Of the two binding sites, disruption of cGMP-specific binding in the NH2-terminal binding site had the greatest effect on cGMP-dependent kinase activation, like cGKI. However, ligand dissociation studies showed that the location of the rapid and slow dissociation sites of cGKII was reversed relative to cGKI. Another set of mutations that prevented cyclic nucleotide binding demonstrated the necessity of the NH2-terminal, rapid dissociation binding site for cyclic nucleotide-dependent activation of cGKII. These findings suggest distinct mechanisms of activation for cGKII and cGKI isoforms. Because cGKII mediates the effects of heat-stable enterotoxins via the cystic fibrosis transmembrane regulator Cl- channel, these findings define a structural target for drug design.


* This work was supported by National Institutes of Heath Grant GM50791.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Neuroscience Laboratories Bldg., 1103 E. Huron St., University of Michigan, Ann Arbor, MI 48104-1687. Tel.: 734-647-3172; Fax: 734-936-2690; E-mail: muhler@umich.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. E. Wall, S. H. Francis, J. D. Corbin, K. Grimes, R. Richie-Jannetta, J. Kotera, B. A. Macdonald, R. R. Gibson, and J. Trewhella
Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase
PNAS, March 4, 2003; 100(5): 2380 - 2385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Taylor, R. Ahmed, M. Begley, and M. D. Uhler
Autoinhibition and Isoform-specific Dominant Negative Inhibition of the Type II cGMP-dependent Protein Kinase
J. Biol. Chem., September 27, 2002; 277(40): 37242 - 37253.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Gurnett, P. A. Liberator, P. M. Dulski, S. P. Salowe, R. G. K. Donald, J. W. Anderson, J. Wiltsie, C. A. Diaz, G. Harris, B. Chang, et al.
Purification and Molecular Characterization of cGMP-dependent Protein Kinase from Apicomplexan Parasites. A NOVEL CHEMOTHERAPEUTIC TARGET
J. Biol. Chem., May 3, 2002; 277(18): 15913 - 15922.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.